Ellevest, Inc. Amgen Inc Transaction History

Ellevest, Inc.

$1.8 Billion
Q3 2024

A detailed history of Ellevest, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Ellevest, Inc. holds 4,089 shares of AMGN stock, worth $1.07 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

4,089

Previous 4,103 0.34%

Holding current value

$1.07 Million

Previous $1.28 Million 2.81%

% of portfolio

0.07%

Previous 0.08%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $4,331 - $4,723	-14 Reduced 0.34%	4,089 $1.32 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $64,373 - $78,230	245 Added 6.35%	4,103 $1.28 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $8,334 - $10,061	31 Added 0.81%	3,858 $1.1 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $9,972 - $11,249	-39 Reduced 1.01%	3,827 $1.1 Million
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $97,080 - $120,528	444 Added 12.97%	3,866 $1.04 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $52,924 - $62,582	-247 Reduced 6.73%	3,422 $759,000
Q1 2023 May 04, 2023	SELL	$225.79 - $275.2 $20,095 - $24,492	-89 Reduced 2.37%	3,669 $886,000
Q4 2022 Feb 03, 2023	BUY	$229.03 - $291.01 $57,715 - $73,334	252 Added 7.19%	3,758 $987,000
Q3 2022 Nov 02, 2022	SELL	$224.46 - $253.15 $110,209 - $124,296	-491 Reduced 12.28%	3,506 $790,000
Q2 2022 Jul 18, 2022	BUY	$230.71 - $256.74 $64,368 - $71,630	279 Added 7.5%	3,997 $972,000
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $160,067 - $177,076	730 Added 24.43%	3,718 $899,000
Q4 2021 Jan 24, 2022	BUY	$198.88 - $227.6 $96,854 - $110,841	487 Added 19.47%	2,988 $672,000
Q3 2021 Oct 19, 2021	SELL	$212.27 - $248.7 $14,434 - $16,911	-68 Reduced 2.65%	2,501 $532,000
Q2 2021 Jul 13, 2021	BUY	$233.58 - $259.14 $50,453 - $55,974	216 Added 9.18%	2,569 $626,000
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $70,123 - $81,717	316 Added 15.51%	2,353 $585,000
Q4 2020 Feb 04, 2021	SELL	$216.38 - $257.67 $43,708 - $52,049	-202 Reduced 9.02%	2,037 $468,000
Q3 2020 Oct 26, 2020	BUY	$234.65 - $260.95 $28,392 - $31,574	121 Added 5.71%	2,239 $569,000
Q2 2020 Jul 06, 2020	BUY	$197.81 - $242.74 $35,803 - $43,935	181 Added 9.34%	2,118 $500,000
Q1 2020 Apr 13, 2020	BUY	$182.24 - $241.7 $293,224 - $388,895	1,609 Added 490.55%	1,937 $393,000
Q4 2019 Feb 05, 2020	BUY	$189.21 - $243.2 $55,627 - $71,500	294 Added 864.71%	328 $79,000
Q3 2019 Oct 08, 2019	BUY	$174.11 - $208.62 $5,919 - $7,093	34 New	34 $7,000
Q2 2019 Aug 20, 2019	SELL	$166.7 - $195.41 $6,834 - $8,011	-41 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$180.87 - $203.88 $7,415 - $8,359	41 New	41 $8,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Account